retatrutide triple agonist gip glp-1 glucagon Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide 40mg Pen | Triple

This may be primarily due to melatonins ability to enhance the placentas antioxidant status and inflammatory response and activation (118)

Wada S, Miyanishi M, Nishimoto Y, Kambe S, Miller RW

Some individuals report feeling an immediate boost in mental clarity and overall well-being when supplementing with glutathione, especially with liposomal forms

Vendor reputation matters enormously

I also need to be transparent about who else I advise on this: my private consulting clients include billionaires in finance, professional athletes, and C-suite executives at major companies people who have access to the best medical teams money can buy and still come to me because they want someone who integrates training, nutrition, and regenerative protocols into one system, not just someone who prescribes compounds